Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins, and auto sales, here’s a quick look at which stocks will be in focus in today's trade:
Results Today
Manoj Jewellers, N2N Technologies, Panorama Studios International, Retro Green Revolution, and Vasudhagama Enterprises will release their quarterly earnings on June 2.
Quarterly Earnings
Titagarh Rail Systems Q4 (Consolidated YoY)
Profit falls 18.4% to Rs 64.5 crore Vs Rs 79 crore
Revenue declines 4.5% to Rs 1,005.6 crore Vs Rs 1,052.4 crore
AstraZeneca Pharma India Q4 (YoY)
Profit zooms 47.5% to Rs 58.3 crore Vs Rs 39.5 crore
Revenue increases 25.4% to Rs 480.5 crore Vs Rs 383.2 crore
Board recommends dividend of Rs 32 per equity share
Genus Power Infrastructures Q4 (Consolidated YoY)
Profit surges 406.5% to Rs 123.3 crore Vs Rs 24.3 crore
Revenue grows 123% to Rs 936.8 crore Vs Rs 420.1 crore
FSN E-Commerce Ventures Nykaa Q4 (Consolidated YoY)
Profit spikes 192.9% to Rs 20.3 crore Vs Rs 6.93 crore
Revenue grows 23.6% to Rs 2,061.8 crore Vs Rs 1668 crore
Apollo Hospitals Enterprise Q4 (Consolidated YoY)
Profit zooms 60.4% to Rs 414.5 crore Vs Rs 258.4 crore
Revenue rises 13.1% to Rs 5,592.2 crore Vs Rs 4,943.9 crore
Board recommends a final dividend of Rs 10 per share
Inox Wind Q4 (Consolidated YoY)
Profit spikes 379.6% to Rs 190.3 crore Vs Rs 39.7 crore
Revenue jumps 141.6% to Rs 1,274.8 crore Vs Rs 527.7 crore
Spandana Sphoorty Financial Q4 (Consolidated YoY)
Loss stands at Rs 434.3 crore Vs profit of Rs 128.6 crore
Revenue falls 38% to Rs 414.8 crore Vs Rs 669.1 crore
Board approves issuance of non-convertible debentures up to Rs 4,000 crore on private placement basis, in tranches
Ashiana Housing Q4 (YoY)
Profit grows 13.8% to Rs 19.7 crore Vs Rs 17.4 crore
Revenue falls 27% to Rs 201.5 crore Vs Rs 275.7 crore
Puravankara Q4 (Consolidated YoY)
Loss widens to Rs 88 crore Vs loss of Rs 6.7 crore
Revenue tanks 41.1% to Rs 541.6 crore Vs Rs 920 crore
Sun TV Network Q4 (Consolidated YoY)
Profit drops 10.4% to Rs 371.6 crore Vs Rs 414.7 crore
Revenue declines 2.2% to Rs 940.6 crore Vs Rs 961.3 crore
Automobile Sales for May
Bajaj Auto (YoY)
Total sales grow 8% to 3.84 lakh units Vs 3.55 lakh units
Domestic sales flat at 2.25 lakh units Vs 2.25 lakh units
Exports zoom 22% to 1.58 lakh units Vs 1.30 lakh units
Hyundai Motor India (YoY)
Total sales decline to 58,701 units Vs 60,774 units
Domestic sales fall to 43,861 units Vs 44,374 units
Export sales drop to 14,840 units Vs 16,400 units
Ashok Leyland (YoY)
Total sales grow 5% to 15,484 units Vs 14,682 units
M&HCV sales increase 11% to 10,282 units Vs 9,243 units
LCV sales drop 4% to 5,202 units Vs 5,439 units
TVS Motor Company (YoY)
Total sales jump 17% to 4.31 lakh units Vs 3.69 lakh units
2-wheeler sales increase 16% to 4.16 lakh units Vs 3.59 lakh units
Electric vehicle sales grow 50% to 27,976 units Vs 18,674 units
Exports up 22% to 1.18 lakh units Vs 96,966 units
3-wheeler sales soar 46% to 15,109 units Vs 10,324 units
Eicher Motors VECV (YoY)
Total sales grow 7.3% to 7,402 units Vs 6,901 units
Eicher Motors Royal Enfield (YoY)
Total sales increase 26% to 89,429 units Vs 71,010 units
Exports surge 82% to 13,609 units Vs 7,479 units
Hero MotoCorp (YoY)
Total sales grow 1.92% to 5.07 lakh units Vs 4.98 lakh units
Domestic sales increase 2% to 4.88 lakh units Vs 4.79 lakh units
Exports up 0.17% to 18,704 units Vs 18,673 units
Maruti Suzuki India (YoY)
Total sales rise 3.2% to 1.8 lakh units Vs 1.74 lakh units
Domestic sales fall 5.3% to 1.48 lakh units Vs 1.57 lakh units
Exports zoom 80% to 31,219 units Vs 17,367 units
Tata Motors (YoY)
Total sales fall 8.6% to 70,187 units Vs Rs 76,766 units
Domestic sales down 10% at 67,429 units Vs 75,173 units
Passenger vehicles sales drop 11% to 42,040 units Vs 47,075 units
Commercial vehicle sales decline 5% to 28,147 units Vs 29,691 units
Mahindra and Mahindra (Automobile YoY)
Total sales grow 17% to 84,110 units
Passenger vehicle sales up 21% at 52,431 units Vs 43,218 units
Exports increase 37% to 3,652 units Vs 2,671 units
3-wheeler sales soar 11% to 6,635 units Vs 5,967 units
Mahindra and Mahindra (Tractor YoY)
Total sales jump 10% to 40,643 units Vs 37,109 units
Domestic sales grow 10% to 38,914 units Vs 35,237 units
Exports fall 8% to 1,729 units Vs 1,872 units
Stocks to Watch
Niva Bupa Health Insurance Company
Reports from CNBC-TV18, quoting sources, indicate that Fettle Tone and Krishnan Ramchandra are likely to sell up to 7.2% of their stake in Niva Bupa Health Insurance Company through block deals. The expected block size for the transaction is around Rs 1,082 crore.
The United States Food and Drug Administration (US FDA) has issued a Form 483 with four observations for Alembic Pharmaceuticals' API-I & II units at Panelav. The inspection took place between May 26 and May 31, 2025, and was a routine, unannounced cGMP inspection. None of the observations were related to data integrity.
The company has received an Engineering, Procurement, and Construction (EPC) order worth Rs 1,068.34 crore from East Central Railway. The order involves the construction of a new broad gauge (BG) rail bridge, including the sub-structure for a double-line track and the superstructure for a single-line track, across the river Ganga between Bikramshila and Katareah stations on the New Railway Line Project.
Godrej Properties, a leading real estate developer, has acquired a 14-acre land parcel in Kharadi-Wagholi, Pune. The company plans to develop a premium group housing project with a potential developable area of 3.7 million square feet, estimated to generate a revenue potential of Rs 4,200 crore.
The United States Food and Drug Administration (USFDA) conducted a current Good Manufacturing Practices (cGMP) inspection at the company’s manufacturing facility in Bommasandra, Bengaluru, during May 26–30, 2025, and issued one observation in Form 483. Meanwhile, the Board has approved the appointment of Prabhakarn Balakrishnan Nair as Senior Management Personnel and Global Chief Manufacturing Officer of the company, effective July 1.
The company has reduced the prices of all chemical grades and manganese ore fines by 5–15%, effective June 2.
The company has received tentative approval from the United States Food and Drug Administration (USFDA) for Rifaximin tablets. Rifaximin is used for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults. As per IQVIA MAT March 2025 data, Rifaximin tablets recorded annual sales of $2,672.9 million in the United States.
The company has won a Rs 1,660 crore inter-state transmission project in Maharashtra. With this addition, its transmission order book now stands at Rs 61,600 crore. Meanwhile, the Board has approved fund raising of up to Rs 4,300 crore via Qualified Institutional Placement (QIP) or other modes.
The company has filed draft papers for the IPO of its subsidiary, Bharat Coking Coal, with SEBI, NSE, and BSE. The proposed IPO will comprise an offer for sale of up to 46.57 crore shares by Coal India.
The company has received a notice from the Assistant Commissioner of Income Tax, Hyderabad, demanding tax amounting to Rs 2,395.81 crore for the Assessment Year 2020–21.
Bulk Deals
Dalmia Cement (Bharat) has sold a 0.57% stake in Indian Energy Exchange at an average price of Rs 200.71 per share. As of March 2025, Dalmia Cement held a 4.17% stake in the company.
Peak XV Partners Investments V and IV have exited Indigo Paints by selling their entire 3.18% shareholding at an average price of Rs 1,046.45 per share. Kotak Mahindra Mutual Fund was the buyer for the 3.18% stake.
Stocks Trade Ex-Date for Income Distribution (InvIT)
Cube Highways Trust
National Highways Infra Trust
Stock in F&O Ban
Manappuram Finance
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
